U.S. federal trademark · Serial No. 79182066 · Reg. No. 5033918
Pharmaceutical and veterinary preparations for treatment of cellular damage due to oxidating agents, DNA damage due to estrogen initiated cancers, general decay of vascular, skeletal and neuro-muscular system, and vitamin D3 deficiency; medicines for treatment of cellular damage due to oxidating agents, DNA damage due to estrogen initiated cancers, general decay of vascular, skeletal and neuro-muscular system, and vitamin D3 deficiency for human and animal use; dietetic substances, namely, antioxidants, chelating agents and D3 vitamins adapted for medical or veterinary use; dietary supplements for humans and animals; dietary food supplements * none of the aforementioned being for use in relation to ocular, periocular or sight fields *
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.